Last updated: June 24, 2021
Sponsor: Xinhua Hospital, Shanghai Jiao Tong University School of Medicine
Overall Status: Active - Recruiting
Phase
N/A
Condition
Nephritis
Nephropathy
Kidney Disease
Treatment
N/AClinical Study ID
NCT04947813
XHEC-C-2020-102-1
All Genders
Study Summary
Eligibility Criteria
Inclusion
Inclusion Criteria:
- Age: up to 99 Years (Child, Adult, Older Adult)
- Sex: All;
- Families and patients with a history of renal hematuria;
- Those who signed the informed consent.
Exclusion
Exclusion Criteria:
- Polycystic kidney disease, hypertensive nephropathy, etc.;
- Kidney biopsy is diagnosed as other primary/secondary kidney disease without type IVcollagen-related kidney disease, including IgA nephropathy, membranous nephropathy,lupus nephritis, etc.
- Incomplete medical history or clinical data.
Study Design
Total Participants: 8165
Study Start date:
January 01, 2021
Estimated Completion Date:
December 31, 2030
Study Description
Connect with a study center
China Xinhua Hospital, Shanghai Jiao Tong University School of Medicine.
Shanghai,
ChinaActive - Recruiting
Not the study for you?
Let us help you find the best match. Sign up as a volunteer and receive email notifications when clinical trials are posted in the medical category of interest to you.